Healthcare startup Nolla Health has launched a pilot program in Utah allowing its AI system to independently analyze face scans and issue initial acne prescriptions to adult residents. The offering costs $4.99 per month and covers eight distinct skin treatments for mild-to-moderate conditions.

The launch marks the first time a state regulatory framework permits an AI system to generate initial prescriptions directly rather than renewing existing medications. To ensure patient safety, the pilot utilizes phased human oversight: the first 100 prescriptions require prior approval from two physicians, the next 400 involve retroactive reviews, and subsequent operations require monthly sampling alongside mandatory escalations for complex cases.

Nolla Health stated that the autonomous system is designed to handle low-acuity cases to alleviate burdens on healthcare providers, referring uncertain diagnostics directly to human dermatologists. The initiative expands on Utah’s recent regulatory changes allowing AI involvement in clinical prescription workflows.

Why it matters

  • State regulatory shifts are enabling autonomous AI systems to write initial medical prescriptions.

  • Phased physician oversight models offer a template for scaling direct-to-consumer AI diagnostics.

  • Low-cost AI clinical triage targets routine healthcare tasks to ease specialist burnout.

Source: theverge.com